Jochen Utikal

51PUBLICATIONS
196CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Oct 01, 2026
Lymph node lymphatic PD-L1 regulates tumor-infiltrating T cells in immune checkpoint-sensitive melanoma.

|Jun 03, 2026
After a Decade of Therapy Revolution in Cutaneous Melanoma-Perspectives on Emerging Treatment Strategies.

|Feb 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Michael Weichenthal, Dirk Debus, Lisa Zimmer

|Oct 16, 2025
Dermal Mitoses Correlate with Surgical Burden in Lentigo Maligna Melanoma: PRAME for Margin Assessment.

Thomas Leibing, Clara Ziemann, Cyrill Géraud

|Oct 04, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy.

Nina Wang, Qian Sun, Daniel Novak

|Jul 27, 2025
Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion.

Yiman Wang, Ke Liu, Yuxin Zhang

Pageof 9

Frequent Collaborators

10 joint publications

Titus Josef Brinker

9 joint publications

Viktor Umansky

9 joint publications

Dirk Schadendorf

7 joint publications

Bastian Schilling